Copyright
©2009 The WJG Press and Baishideng.
World J Gastroenterol. Apr 14, 2009; 15(14): 1719-1729
Published online Apr 14, 2009. doi: 10.3748/wjg.15.1719
Published online Apr 14, 2009. doi: 10.3748/wjg.15.1719
TCDD concentration (nmol/L) | Percentage of cell cycle (%) | ||
G0/G1 | S | G2/M | |
Control | 54.47 ± 0.45 | 39.10 ± 1.39 | 6.43 ± 1.48 |
0.01 | 60.47 ± 3.11a | 33.20 ± 2.51 | 6.33 ± 1.12 |
0.1 | 66.07 ± 0.80b | 28.67 ± 3.08b | 5.33 ± 2.34 |
1 | 67.53 ± 2.57b | 25.73 ± 4.56b | 6.73 ± 2.06 |
10 | 67.20 ± 4.33b | 25.03 ± 5.31b | 7.77 ± 1.99 |
100 | 68.57 ± 5.57b | 25.10 ± 7.41b | 6.33 ± 1.96 |
- Citation: Peng TL, Chen J, Mao W, Liu X, Tao Y, Chen LZ, Chen MH. Potential therapeutic significance of increased expression of aryl hydrocarbon receptor in human gastric cancer. World J Gastroenterol 2009; 15(14): 1719-1729
- URL: https://www.wjgnet.com/1007-9327/full/v15/i14/1719.htm
- DOI: https://dx.doi.org/10.3748/wjg.15.1719